The US based private equity firm The Carlyle Group has agreed to acquire 74% stake in SeQuent Scientific Limited, the largest pure-play animal healthcare company in India, for $210 million (Rs.1587 crore), company said on Friday. Carlyle will buy shares at a price of Rs.86 apiece.
— The Economic Times
Nishith Desai Associates advised SeQuent and the promoters of Sequent, including Arun Kumar and family with M&A co-head and leader Simone Reis, leader Shreyas Bhushan and senior lawyer Amudavalli Kannan.
AZB & Partners advised The Carlyle Group led by a team of partners Zia Mody, Darshika Kothari and Sayak Maity, senior associates Sneha Nagvekar and Pankhuri Govil.
White & Case also acted for Carlyle.
2020-05-08
Deal value: $210m (Rs 1,580 crore)
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.
Click to show comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
threads most popular
thread most upvoted
comment newest
first oldest
first
threads most popular
thread most upvoted
comment newest
first oldest
first